Ginkgo Bioworks Holdings, Inc. (DNABW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 60M 120M 180M Q3 '20: 13.3M Q4 '20: 32.1M Q1 '21: 44.1M Q2 '21: 43.6M Q3 '21: 77.6M Q4 '21: 148.5M Q1 '22: 168.4M Q2 '22: 144.6M Q3 '22: 66.4M Q4 '22: 98.3M Q1 '23: 80.7M Q2 '23: 80.6M Q3 '23: 55.4M Q4 '23: 34.8M Q1 '24: 37.9M Q2 '24: 56.2M Q3 '24: 89M Q4 '24: 43.8M Q1 '25: 38.2M Q2 '25: 39.1M Q3 '25: 38.8M Q4 '25: 33.4M Q1 '26: 19.5M Q2 '26: 20.2M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 15M 30M 45M Q1 '25: 34.1M Q2 '25: 33.8M Q1 '26: 16.4M Q2 '26: 18.4M Q1 '25 Q2 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q3 '20: -34.4M Q4 '20: -55.9M Q1 '21: -57.1M Q2 '21: -59.9M Q3 '21: -26.7M Q4 '21: -1.7B Q1 '22: -675.4M Q2 '22: -647.8M Q3 '22: -654.9M Q4 '22: -230.9M Q1 '23: -215.7M Q2 '23: -184.2M Q3 '23: -286.4M Q4 '23: -178.1M Q1 '24: -178M Q2 '24: -222.9M Q3 '24: -55.2M Q4 '24: -103.6M Q1 '25: -81M Q2 '25: -58.2M Q3 '25: -90M Q4 '25: -70.8M Q1 '26: -71.4M Q2 '26: -58.5M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q1 '20: -25.5M Q2 '20: -28.7M Q3 '20: -26.1M Q4 '20: -46.9M Q1 '21: -73.6M Q2 '21: -53.9M Q3 '21: -101.9M Q4 '21: -1.6B Q1 '22: -590.5M Q2 '22: -668.8M Q3 '22: -670.1M Q4 '22: -175.5M Q1 '23: -205M Q2 '23: -173.3M Q3 '23: -302.9M Q4 '23: -211.7M Q1 '24: -165.9M Q2 '24: -217.2M Q3 '24: -56.4M Q4 '24: -107.5M Q1 '25: -91M Q2 '25: -60.3M Q3 '25: -80.8M Q4 '25: -80.8M Q1 '26: -82.6M Q2 '26: -46.7M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Cost of Revenue Quarterly

0 2M 4M 6M Q1 '25: 4.1M Q2 '25: 5.4M Q1 '26: 3.1M Q2 '26: 1.7M Q1 '25 Q2 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-180M -120M -60M 0 60M 120M 180M Q4 '20: -59.3M Q1 '21: -48.1M Q2 '21: -34.9M Q3 '21: -5.2M Q4 '21: -165.5M Q1 '22: -19.9M Q2 '22: -99.4M Q3 '22: -28.4M Q4 '22: -104.5M Q1 '23: -90.6M Q2 '23: -73.5M Q3 '23: -73.6M Q4 '23: -57.8M Q1 '24: -89.3M Q2 '24: -84.4M Q3 '24: -103.5M Q4 '24: -42.4M Q1 '25: -51.5M Q2 '25: -40.3M Q3 '25: -31.6M Q4 '25: -47.7M Q1 '26: -46.7M Q2 '26: -44.3M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-180M -120M -60M 0 60M 120M 180M Q4 '20: -78.8M Q1 '21: -70.1M Q2 '21: -58.9M Q3 '21: -10.7M Q4 '21: -170.7M Q1 '22: -23.5M Q2 '22: -109M Q3 '22: -41.8M Q4 '22: -130.2M Q1 '23: -110M Q2 '23: -87.1M Q3 '23: -77.9M Q4 '23: -61.3M Q1 '24: -96M Q2 '24: -111.4M Q3 '24: -118.6M Q4 '24: -56.1M Q1 '25: -59.1M Q2 '25: -40.3M Q3 '25: -31.6M Q4 '25: -47.7M Q1 '26: -48.6M Q2 '26: -46.9M Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 700M 1.4B 2.1B Q2 '21: 1.3B Q3 '21: 1.3B Q1 '22: 1.6M Q2 '22: 1.6B Q3 '22: 1.6B Q1 '23: 1.9B Q2 '23: 1.9B Q3 '23: 48.8M Q1 '24: 50.1M Q2 '24: 51.4M Q3 '24: 52.2M Q1 '25: 54.2M Q2 '25: 54.9M Q3 '25: 55.6M Q1 '26: 59.6M Q2 '26: 62.1M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-60.00 -40.00 -20.00 0.00 20.00 40.00 60.00 Q4 '21: -1.39 Q1 '23: -49.94 Q2 '23: -49.62 Q3 '23: -55.42 Q4 '23: -10.69 Q1 '24: -13.90 Q2 '24: -18.04 Q3 '24: -12.91 Q4 '24: -10.59 Q1 '25: -8.95 Q2 '25: -5.82 Q3 '25: -6.19 Q4 '25: -5.65 Q1 '26: -5.36 Q2 '26: -5.01 Q4 '21 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.